EE9900566A - Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostised - Google Patents

Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostised

Info

Publication number
EE9900566A
EE9900566A EEP199900566A EEP9900566A EE9900566A EE 9900566 A EE9900566 A EE 9900566A EE P199900566 A EEP199900566 A EE P199900566A EE P9900566 A EEP9900566 A EE P9900566A EE 9900566 A EE9900566 A EE 9900566A
Authority
EE
Estonia
Prior art keywords
compositions containing
helicobacter pylori
vaccine compositions
containing helicobacter
flge polypeptide
Prior art date
Application number
EEP199900566A
Other languages
English (en)
Inventor
Berglindh Thomas
Mellg�rd Bj�rn
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9900566A publication Critical patent/EE9900566A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP199900566A 1997-06-12 1998-06-08 Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostised EE9900566A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702242A SE9702242D0 (sv) 1997-06-12 1997-06-12 Vaccine compositions V
PCT/SE1998/001093 WO1998056816A1 (en) 1997-06-12 1998-06-08 VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE

Publications (1)

Publication Number Publication Date
EE9900566A true EE9900566A (et) 2000-06-15

Family

ID=20407351

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900566A EE9900566A (et) 1997-06-12 1998-06-08 Helicobacter pylori FlgE polüpeptiidi sisaldavad vaktsiinikoostised

Country Status (21)

Country Link
EP (1) EP1009764A1 (et)
JP (1) JP2002507118A (et)
KR (1) KR20010013699A (et)
CN (1) CN1259960A (et)
AR (1) AR012896A1 (et)
AU (1) AU8048798A (et)
BR (1) BR9810026A (et)
CA (1) CA2293293A1 (et)
EE (1) EE9900566A (et)
HU (1) HUP0003164A3 (et)
ID (1) ID23052A (et)
IL (1) IL133144A0 (et)
IS (1) IS5288A (et)
NO (1) NO996132L (et)
NZ (1) NZ501427A (et)
PL (1) PL337503A1 (et)
SE (1) SE9702242D0 (et)
SK (1) SK173099A3 (et)
TR (1) TR199903060T2 (et)
WO (1) WO1998056816A1 (et)
ZA (1) ZA984696B (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784687A (zh) * 2015-04-27 2015-07-22 苏州大学附属第一医院 重组绿脓杆菌鞭毛钩蛋白FlgE的用途
CN113425717B (zh) * 2021-04-22 2023-06-16 成都欧林生物科技股份有限公司 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用
CN116535472B (zh) * 2023-05-31 2024-04-30 四川大学华西医院 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用
CN118105473B (zh) * 2024-04-30 2024-08-16 成都欧林生物科技股份有限公司 一种预防或治疗Hp感染口服免疫原性组合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la

Also Published As

Publication number Publication date
NO996132L (no) 2000-01-28
HUP0003164A2 (hu) 2000-12-28
NZ501427A (en) 2000-09-29
JP2002507118A (ja) 2002-03-05
BR9810026A (pt) 2000-09-19
IL133144A0 (en) 2001-03-19
CN1259960A (zh) 2000-07-12
HUP0003164A3 (en) 2001-10-29
WO1998056816A1 (en) 1998-12-17
IS5288A (is) 1999-12-08
SE9702242D0 (sv) 1997-06-12
AU8048798A (en) 1998-12-30
TR199903060T2 (xx) 2000-09-21
ZA984696B (en) 1999-01-04
ID23052A (id) 2000-01-20
PL337503A1 (en) 2000-08-28
SK173099A3 (en) 2000-06-12
KR20010013699A (ko) 2001-02-26
EP1009764A1 (en) 2000-06-21
AR012896A1 (es) 2000-11-22
NO996132D0 (no) 1999-12-10
CA2293293A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
EE04481B1 (et) Peptiididel ja adjuvantidel baseeruv farmatseutiline kompositsioon immuunmodulatsiooni jaoks
FI955042A7 (fi) Syklosporiinia sisältävä jauhemainen koostumus
NO984881D0 (no) Oralt farmas°ytisk preparat inneholdende ibandronat
NO20001914D0 (no) <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
NO975490D0 (no) Heliobacter pylori antigener og vaksinesammensetninger
FI991302L (fi) Parannetut farmaseuttiset koostumukset
DE69725482D1 (de) Härtbare Siliconzusammensetzungen
FI972054L (fi) Immunogeenisiä koostumuksia
EE9800334A (et) Helicobacter pylor' iga seotud nukleiinhapete ja aminohapete järjestused ja nendest tuletatud vaktsiinikompositsioonid
ID23772A (id) Komposisi-komposisi melalui mulut
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
ID16781A (id) Formulasi-formulasi farmasi
DE69510840D1 (de) Härtbare Organopolysiloxanzusammensetzungen
PT925273E (pt) Composicoes farmaceuticas contendo acidos 4-oxobutanoicos
DE69804573D1 (de) Organopolysiloxan-Zusammensetzungen
EE9900440A (et) Farmatseutilised kompositsioonid
AU1698699A (en) (helicobacter pylori) vaccine formulations
DE69815138D1 (de) Phosphoniumsalz-zusammensetzung
IS5288A (is) Bóluefnablöndur sem innihalda FlgE pólýpeptíð Helicobacter pylori
NO981407D0 (no) Protein fra Helicobacter pylori
FI973335A7 (fi) Helicobacter pylori-antigeeni
HK1026914A (en) Vaccine compositions comprising the helicobacter pylori flge polypeptide
AU8048698A (en) Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide
NO994436L (no) Farmasöytiske sammensetninger
AU7945798A (en) Vaccine compositions comprising the (helicobacter pylori) 26kda polypeptide